These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7163561)

  • 21. Prognosis in patients with cirrhosis and mild portal hypertension.
    Ytting H; Møller S; Henriksen JH; Larsen K; Bendtsen F
    Scand J Gastroenterol; 2006 Dec; 41(12):1446-53. PubMed ID: 17101576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.
    Baron A; Gulberg V; Sauter G; Waggershauser T; Reiser M; Gerbes AL
    Hepatogastroenterology; 1998; 45(24):2315-21. PubMed ID: 9951915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serology of total E immunoglobulins in liver cirrhosis].
    Linoli G
    Pathologica; 1987; 79(1064):773-80. PubMed ID: 3503231
    [No Abstract]   [Full Text] [Related]  

  • 25. [Role of monomeric and dimeric immunoglobulin A in the hypergammaglobulinemia of alcoholic cirrhosis].
    André F; André C
    Biol Gastroenterol (Paris); 1976; 9(2):147-50. PubMed ID: 999973
    [No Abstract]   [Full Text] [Related]  

  • 26. [Role of immunomorphological methods in the preoperative examination of patients with the intrahepatic form of portal hypertension].
    Patsiora MD; Kniazeva GD; Ershov IuA; Morozov VA; Minashkina LP
    Khirurgiia (Mosk); 1981 Oct; (10):81-4. PubMed ID: 7332634
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sarcoidosis and the liver].
    Ganne-Carrié N; Guettier C; Ziol M; Beaugrand M; Trinchet JC
    Ann Med Interne (Paris); 2001 Mar; 152(2):103-7. PubMed ID: 11357046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
    François E; García-Pagán JC; Bru C; Feu F; Gilabert R; Escorsell A; Bosch J; Rodés J
    Gastroenterol Hepatol; 1997 Jan; 20(1):1-4. PubMed ID: 9072189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of liver cirrhosis from internal medicine viewpoint].
    Müting D
    Med Welt; 1969 Apr; 20(15):840-5. PubMed ID: 5784371
    [No Abstract]   [Full Text] [Related]  

  • 30. Hyperglobulinaemia in liver disease.
    Prytz H; Bjorneboe M
    Lancet; 1973 Jul; 2(7821):150-1. PubMed ID: 4124069
    [No Abstract]   [Full Text] [Related]  

  • 31. Helicobacter pylori on portal hypertension-related hepatic encephalopathy.
    Kountouras J; Polyzos SA; Katsinelos P; Tzivras D; Boziki M; Gavalas E; Zavos C; Vardaka E; Romiopoulos I; Anastasiadis S; Tsiaousi E; Kountouras C; Xiromerisiou G; Deretzi G
    Immunopharmacol Immunotoxicol; 2017 Apr; 39(2):105-106. PubMed ID: 28211305
    [No Abstract]   [Full Text] [Related]  

  • 32. Liver function reserve in surgical treatment of patients with portal hypertension: report of 146 cases.
    Gu DY; Xu WG; Lin ZP; Luo Z; Wu HF
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):515-8. PubMed ID: 14607677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice.
    Schomerus H; Schreiegg J
    Z Gastroenterol; 1993 Apr; 31(4):231-4. PubMed ID: 8493802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lactulose in treatment of hepatic encephalopathy in patient with liver cirrhosis].
    Shuliat'ev IS; Il'chenko LIu; Vinnitskaia EV; Petrakov AV; Sil'verstrova SIu
    Eksp Klin Gastroenterol; 2002; (5):38-41, 127. PubMed ID: 12619575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological subclassification of cirrhosis based on histological-haemodynamic correlation.
    Kumar M; Sakhuja P; Kumar A; Manglik N; Choudhury A; Hissar S; Rastogi A; Sarin SK
    Aliment Pharmacol Ther; 2008 May; 27(9):771-9. PubMed ID: 18284653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of splenectomy on T cell subsets of peripheral blood lymphocytes in portal hypertension].
    Takeda A; Fujimoto Y; Yui S; Sakaguchi S; Kato N
    Nihon Geka Gakkai Zasshi; 1985 Apr; 86(4):507. PubMed ID: 3873597
    [No Abstract]   [Full Text] [Related]  

  • 37. [Idiopathic ductopenia in adults as a cause of cryptogenic cirrhosis and complications of portal hypertension].
    Rodríguez Martínez D; Fernández Rodríguez CM; Rodríguez Prada I; Pereira Bueno S; Butrón M; Colina F
    Gastroenterol Hepatol; 1998 Jan; 21(1):10-2. PubMed ID: 9503746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biophysics and clinical practice for regenerative processes in cirrhosis of the liver/of liver cirrhosis assisted by Delta-S Entropy Variation Systems.
    Marineo G; Fesce E
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):365-70. PubMed ID: 17108866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long course and prognostic factors of virus-induced cirrhosis of the liver.
    Gentilini P; Laffi G; La Villa G; Romanelli RG; Buzzelli G; Casini-Raggi V; Melani L; Mazzanti R; Riccardi D; Pinzani M; Zignego AL
    Am J Gastroenterol; 1997 Jan; 92(1):66-72. PubMed ID: 8995940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Case contribution to the study of the relations between serum immunoglobulin changes and liver disease].
    Pedini G; Taiuti L; Ranieri MG; Zaietta P; Perani G
    G Clin Med; 1977; 58(9-10):381-92. PubMed ID: 598630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.